Phari

Personal opinion only

[Phari @Phari]

ICD 10 is coming and these are some new codes. Love the sucked into jet engine one

[Morie Gertz @MorieGertz]

I was in notified by the same insurance company, Blue Cross and Blue Shield of Minnesota that the patient has to fail thalidomide first before receiving Len. So I am now in the year 2002 please RT this so executives at Blue Cross and Blue Shield. See what a bunch of morons they R

[Phari @Phari]

@kansagraMD @VincentRK Not to forget the brave patients who joined the trials; industry - small biotechs and big pharma that led R&D , invented new molecules; and regulators FDA and others that shaped trial designs and approvals. But what a wonderful story indeed.

[James Wu | 吴简凡 MD @JamesFanWu]

🚨 TIL therapy is finally breaking through in solid tumors

New review: Evolving TIL therapy in metastatic melanoma

📊 Visual summary below

🔗 Full article: https://t.co/s3Ej6rQJFO

#Oncology #Immunotherapy #Melanoma #CellTherapy #TIL

[Phari @Phari]

@timfenske True .. such a great all purpose tool picks up everything from the mundane to anionic IgA paraproteins !

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Check our viewpoint published @JAMA_current #MedEd

Abstract Factory—Research Culture Harming Medical Education

The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor.

➡️https://t.co/IMBhy45L1K

@utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG

[Vincent Rajkumar @VincentRK]

Just out in @NEJM
Effective therapy of extra medullary relapsed myeloma with teclistamab plus talquetamab (Tec-Tal). RedirecTT-1 #ASH25
@myelomaMD @szusmani @mvmateos

80% response rate.
60% PFS at 12 months.
https://t.co/fqAPu4pMUc

[Phari @Phari]

@qatarairways Thank you 🙏.. for taking care of this

[Phari @Phari]

@qatarairways Your app or website does not allow one to add American FF number to my booking. What is the value of being one world top tier if we cannot add it seamlessly to Qatar bookings and enjoy your one world partnership?

[Phari @Phari]

@traveloneworld ..

[Vincent Rajkumar @VincentRK]

@Phari @ASTCT Definitely. ASCT, Early or late, must be considered in all transplant eligible patients

[Phari @Phari]

BMT @ASTCT .. please note that as front line transplant for myeloma is used less and less we still discuss collection of cells and offer it to patients.

[Vincent Rajkumar @VincentRK]

@Phari @SurbhiSidanaMD @hhashmi87 @TomBmt133 I guess we are the exception. We still collect and store routinely!

[Phari @Phari]

@VincentRK @SurbhiSidanaMD @hhashmi87 @TomBmt133 Doing well.. recovering from the burnout and learning the broad financial and regulatory aspects of drug development that we never got to see as PIs or triallists.

[Phari @Phari]

@VincentRK @SurbhiSidanaMD @hhashmi87 @TomBmt133 Unfortunately this will be a waning option as front line transplant/ cell collection recedes … people with bags in the freezer become a rarity ! Unless we find a way to pay for pheresis and storage

[Vincent Rajkumar @VincentRK]

Here are my Top 5 #ASH25 @ASH_hematology myeloma abstracts. #ASH25VR

My Top 5 are based on new data, clinical impact, & methodology with links to the full abstract. Bookmark!

Thread with countdown 👇

[Phari @Phari]

@timfenske @bdermanmd And this approach which we pioneered in 2018 first is our go to when steroids are not working. Early initiation is key .. full series from 2022
https://t.co/w5uyBnGiKx

[Phari @Phari]

@SewantiLimaye @AACR2025 @VivekSubbiah @ANaingMD @geoff_oxnard @DrHaddadRobert @HeadNeckMD @SGoswamiMDPhD @DrChoueiri Congratulations Aditya and was so great seeing you Sewanti..😊

[Sewanti Limaye 🇮🇳🇺🇸 @SewantiLimaye]

Truly honoured to be @AACR2025 & speak on #Precision in #RareCancers “A view from India”. Amazing to share the stage with the great @Dr_R_Kurzrock and @youngkwangchae #DART ! @UmutDisel @SGoswamiMDPhD thank you for being the audience! 🙏 @RFhospital @OncoAlert @oncodaily

[Sewanti Limaye 🇮🇳🇺🇸 @SewantiLimaye]

@AACR2025 @VivekSubbiah @ANaingMD @geoff_oxnard @DrHaddadRobert @HeadNeckMD @SGoswamiMDPhD @DrChoueiri @Phari But truly overjoyed and overwhelmed by @AdityaSunavs #OralPresentation #Penpulimab #NPC @Dr_R_Kurzrock @VivekSubbiah @BalazsHalmosMD @ANaingMD @Phari @HeadNeckMD @OncoAlert @oncodaily @OncBrothers #BrotherSisterGoals

[chadi nabhan MD, MBA, FACP @chadinabhan]

From Lab to Startup: Dr. Simrit Parmar on Launching Cellenkos https://t.co/Uv1Mu35uhg via @YouTube

The world of startups is hard and filled w challenges. The inspiring journey of @spa718 shows tenacity and perseverance that we can all learn from.
My last #HealthcareUnfiltered

[Jame Abraham, MD, FACP @jamecancerdoc]

Thank you ⁦@anantm⁩ and his colleagues from ⁦@EmoryUniversity⁩ for this must read - excellent review for clinicians on Artificial Intelligence https://t.co/PUd0iD60xT ⁦@JCOOP_ASCO⁩ ⁦@OncoAlert⁩ ⁦@EthicsdoctorP⁩